{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:43:02Z","timestamp":1778942582472,"version":"3.51.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-218","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T04:09:45Z","timestamp":1367467785000},"source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of hypoxia in a feline model of head and neck cancer using 64Cu-ATSM positron emission tomography\/computed tomography"],"prefix":"10.1186","volume":"13","author":[{"given":"Elizabeth A","family":"Ballegeer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole J","family":"Madrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalen W","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"McNiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"issue":"5706","key":"3901_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK: Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005, 307 (5706): 58-62. 10.1126\/science.1104819.","journal-title":"Science"},{"issue":"3","key":"3901_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.semradonc.2004.04.008","volume":"14","author":"P Vaupel","year":"2004","unstructured":"Vaupel P: Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol. 2004, 14 (3): 198-206. 10.1016\/j.semradonc.2004.04.008.","journal-title":"Semin Radiat Oncol"},{"issue":"6976","key":"3901_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/427695a","volume":"427","author":"TP Padera","year":"2004","unstructured":"Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK: Pathology: cancer cells compress intratumour vessels. Nature. 2004, 427 (6976): 695-10.1038\/427695a.","journal-title":"Nature"},{"issue":"2","key":"3901_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A: Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007, 26 (2): 225-239. 10.1007\/s10555-007-9055-1.","journal-title":"Cancer Metastasis Rev"},{"key":"3901_CR5","volume-title":"Radiobiology for the Radiologist","author":"EJ Hall","year":"2012","unstructured":"Hall EJ, Giaccia AJ: Oxygen effec and re-oxygenation. Radiobiology for the Radiologist. Edited by: Hall EJ, Giaccia AJ. 2012, Philadelphia: Lipponcott, Williams & Wilkins, 7","edition":"7"},{"issue":"7","key":"3901_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1365-2559.2011.03806.x","volume":"58","author":"AW Eckert","year":"2011","unstructured":"Eckert AW, Lautner MH, Schutze A, Taubert H, Schubert J, Bilkenroth U: Coexpression of hypoxia-inducible factor-1alpha and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients. Histopathology. 2011, 58 (7): 1136-1147. 10.1111\/j.1365-2559.2011.03806.x.","journal-title":"Histopathology"},{"issue":"1","key":"3901_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0167-8140(93)90025-4","volume":"26","author":"M Hockel","year":"1993","unstructured":"Hockel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, Knapstein PG, Vaupel P: Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 1993, 26 (1): 45-50. 10.1016\/0167-8140(93)90025-4.","journal-title":"Radiother Oncol"},{"issue":"2","key":"3901_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.canlet.2010.03.019","volume":"295","author":"M Perez-Sayans","year":"2010","unstructured":"Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Diz PG, Rey JM, Garcia-Garcia A: Multidrug resistance in oral squamous cell carcinoma: the role of vacuolar ATPases. Cancer Lett. 2010, 295 (2): 135-143. 10.1016\/j.canlet.2010.03.019.","journal-title":"Cancer Lett"},{"issue":"1","key":"3901_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2011.08.017","volume":"313","author":"M Perez-Sayans","year":"2011","unstructured":"Perez-Sayans M, Suarez-Penaranda JM, Pilar GD, Barros-Angueira F, Gandara-Rey JM, Garcia-Garcia A: Hypoxia-inducible factors in OSCC. Cancer Lett. 2011, 313 (1): 1-8. 10.1016\/j.canlet.2011.08.017.","journal-title":"Cancer Lett"},{"issue":"21","key":"3901_CR10","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/sj.onc.1206385","volume":"22","author":"A Unruh","year":"2003","unstructured":"Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R, Richter E, Katschinski DM, Wenger RH: The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene. 2003, 22 (21): 3213-3220. 10.1038\/sj.onc.1206385.","journal-title":"Oncogene"},{"issue":"1","key":"3901_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.oraloncology.2008.03.017","volume":"45","author":"JL Roh","year":"2009","unstructured":"Roh JL, Cho KJ, Kwon GY, Ryu CH, Chang HW, Choi SH, Nam SY, Kim SY: The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral Oncol. 2009, 45 (1): 63-68. 10.1016\/j.oraloncology.2008.03.017.","journal-title":"Oral Oncol"},{"issue":"2","key":"3901_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","volume":"38","author":"DM Brizel","year":"1997","unstructured":"Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997, 38 (2): 285-289. 10.1016\/S0360-3016(97)00101-6.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"3901_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.nucmedbio.2011.02.002","volume":"38","author":"SR Bowen","year":"2011","unstructured":"Bowen SR, van der Kogel AJ, Nordsmark M, Bentzen SM, Jeraj R: Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling. Nucl Med Biol. 2011, 38 (6): 771-780. 10.1016\/j.nucmedbio.2011.02.002.","journal-title":"Nucl Med Biol"},{"issue":"9","key":"3901_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12149-011-0508-9","volume":"25","author":"M Kikuchi","year":"2011","unstructured":"Kikuchi M, Yamane T, Shinohara S, Fujiwara K, Hori SY, Tona Y, Yamazaki H, Naito Y, Senda M: 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma. Ann Nucl Med. 2011, 25 (9): 625-633. 10.1007\/s12149-011-0508-9.","journal-title":"Ann Nucl Med"},{"issue":"3","key":"3901_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.radonc.2011.05.079","volume":"99","author":"CA Maftei","year":"2011","unstructured":"Maftei CA, Shi K, Bayer C, Astner ST, Vaupel P: Comparison of (immuno-)fluorescence data with serial [(1)(8)F]Fmiso PET\/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers. Radiother Oncol. 2011, 99 (3): 412-417. 10.1016\/j.radonc.2011.05.079.","journal-title":"Radiother Oncol"},{"issue":"5","key":"3901_CR16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.ijrobp.2004.12.057","volume":"61","author":"JA O'Donoghue","year":"2005","unstructured":"O'Donoghue JA, Zanzonico P, Pugachev A, Wen B, Smith-Jones P, Cai S, Burnazi E, Finn RD, Burgman P, Ruan S: Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: comparative study featuring microPET imaging, pOo2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. Int J Radiat Oncol Biol Phys. 2005, 61 (5): 1493-1502. 10.1016\/j.ijrobp.2004.12.057.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3901_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tripleo.2011.04.006","volume":"113","author":"T Yamada","year":"2012","unstructured":"Yamada T, Uchida M, Kwang-Lee K, Kitamura N, Yoshimura T, Sasabe E, Yamamoto T: Correlation of metabolism\/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2012, 113 (4): 464-471. 10.1016\/j.tripleo.2011.04.006.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"3901_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","volume":"100","author":"J Overgaard","year":"2011","unstructured":"Overgaard J: Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck\u2014a systematic review and meta-analysis. Radiother Oncol. 2011, 100 (1): 22-32. 10.1016\/j.radonc.2011.03.004.","journal-title":"Radiother Oncol"},{"key":"3901_CR19","first-page":"455","volume-title":"Withrow and MacEwen's Small Animal Clinical Oncology. Volume 4th","author":"JM Liptak","year":"2007","unstructured":"Liptak JM, Withrow SJ: Oral tumors. Withrow and MacEwen's Small Animal Clinical Oncology. Volume 4th. Edited by: Withrow SJ, Vail DM. 2007, St. Louis: Saunders Elsevier Inc, 455-510."},{"issue":"11","key":"3901_CR20","first-page":"1202","volume":"169","author":"CR Dorn","year":"1976","unstructured":"Dorn CR, Priester WA: Epidemiologic analysis of oral and pharyngeal cancer in dogs, cats, horses, and cattle. J Am Vet Med Assoc. 1976, 169 (11): 1202-1206.","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"3901_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1939-1676.2003.tb02478.x","volume":"17","author":"ER Bertone","year":"2003","unstructured":"Bertone ER, Snyder LA, Moore AS: Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats. J Vet Intern Med. 2003, 17 (4): 557-562. 10.1111\/j.1939-1676.2003.tb02478.x.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"3901_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2460\/ajvr.68.4.349","volume":"68","author":"EA McNiel","year":"2007","unstructured":"McNiel EA, Carmella SG, Heath LA, Bliss RL, Le KA, Hecht SS: Urinary biomarkers to assess exposure of cats to environmental tobacco smoke. Am J Vet Res. 2007, 68 (4): 349-353. 10.2460\/ajvr.68.4.349.","journal-title":"Am J Vet Res"},{"issue":"3","key":"3901_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1354\/vp.41-3-209","volume":"41","author":"LA Snyder","year":"2004","unstructured":"Snyder LA, Bertone ER, Jakowski RM, Dooner MS, Jennings-Ritchie J, Moore AS: p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma. Vet Pathol. 2004, 41 (3): 209-214. 10.1354\/vp.41-3-209.","journal-title":"Vet Pathol"},{"issue":"1","key":"3901_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1476-5810.2006.00091.x","volume":"4","author":"JS Looper","year":"2006","unstructured":"Looper JS, Malarkey DE, Ruslander D, Proulx D, Thrall DE: Epidermal growth factor receptor expression in feline oral squamous cell carcinomas. Vet Comp Oncol. 2006, 4 (1): 33-40. 10.1111\/j.1476-5810.2006.00091.x.","journal-title":"Vet Comp Oncol"},{"issue":"10","key":"3901_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jfms.2010.04.010","volume":"12","author":"S Sabattini","year":"2010","unstructured":"Sabattini S, Marconato L, Zoff A, Morini M, Scarpa F, Capitani O, Bettini G: Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma. J Feline Med Surg. 2010, 12 (10): 760-768. 10.1016\/j.jfms.2010.04.010.","journal-title":"J Feline Med Surg"},{"issue":"5","key":"3901_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1354\/vp.40-5-496","volume":"40","author":"SL Beam","year":"2003","unstructured":"Beam SL, Rassnick KM, Moore AS, McDonough SP: An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Vet Pathol. 2003, 40 (5): 496-500. 10.1354\/vp.40-5-496.","journal-title":"Vet Pathol"},{"issue":"2\u20133","key":"3901_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jcpa.2006.06.001","volume":"135","author":"A Hayes","year":"2006","unstructured":"Hayes A, Scase T, Miller J, Murphy S, Sparkes A, Adams V: COX-1 and COX-2 expression in feline oral squamous cell carcinoma. J Comp Pathol. 2006, 135 (2\u20133): 93-99.","journal-title":"J Comp Pathol"},{"issue":"4","key":"3901_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.plefa.2007.01.006","volume":"76","author":"L DiBernardi","year":"2007","unstructured":"DiBernardi L, Dore M, Davis JA, Owens JG, Mohammed SI, Guptill CF, Knapp DW: Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment. Prostaglandins Leukot Essent Fat Acids. 2007, 76 (4): 245-250. 10.1016\/j.plefa.2007.01.006.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"5","key":"3901_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/1097-0215(20001020)90:5<237::AID-IJC1>3.0.CO;2-T","volume":"90","author":"MW Dewhirst","year":"2000","unstructured":"Dewhirst MW, Klitzman B, Braun RD, Brizel DM, Haroon ZA, Secomb TW: Review of methods used to study oxygen transport at the microcirculatory level. Int J Cancer. 2000, 90 (5): 237-255. 10.1002\/1097-0215(20001020)90:5<237::AID-IJC1>3.0.CO;2-T.","journal-title":"Int J Cancer"},{"issue":"4","key":"3901_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1740-8261.2005.00065.x","volume":"46","author":"M Bruehlmeier","year":"2005","unstructured":"Bruehlmeier M, Kaser-Hotz B, Achermann R, Bley CR, Wergin M, Schubiger PA, Ametamey SM: Measurement of tumor hypoxia in spontaneous canine sarcomas. Vet Radiol Ultrasound. 2005, 46 (4): 348-354. 10.1111\/j.1740-8261.2005.00065.x.","journal-title":"Vet Radiol Ultrasound"},{"issue":"5","key":"3901_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.mibio.2004.06.007","volume":"6","author":"SS Foo","year":"2004","unstructured":"Foo SS, Abbott DF, Lawrentschuk N, Scott AM: Functional imaging of intratumoral hypoxia. Mol Imaging Biol. 2004, 6 (5): 291-305. 10.1016\/j.mibio.2004.06.007.","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"3901_CR32","first-page":"989","volume":"47","author":"H Yuan","year":"2006","unstructured":"Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW: Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med. 2006, 47 (6): 989-998.","journal-title":"J Nucl Med"},{"issue":"1","key":"3901_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2307\/3579536","volume":"148","author":"C Azuma","year":"1997","unstructured":"Azuma C, Raleigh JA, Thrall DE: Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiat Res. 1997, 148 (1): 35-42. 10.2307\/3579536.","journal-title":"Radiat Res"},{"issue":"2","key":"3901_CR34","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijrobp.2005.09.010","volume":"64","author":"MM Kleiter","year":"2006","unstructured":"Kleiter MM, Thrall DE, Malarkey DE, Ji X, Lee DY, Chou SC, Raleigh JA: A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int J Radiat Oncol Biol Phys. 2006, 64 (2): 592-602. 10.1016\/j.ijrobp.2005.09.010.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3901_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0360-3016(00)01505-4","volume":"49","author":"JA Raleigh","year":"2001","unstructured":"Raleigh JA, Chou SC, Bono EL, Thrall DE, Varia MA: Semiquantitative immunohistochemical analysis for hypoxia in human tumors. Int J Radiat Oncol Biol Phys. 2001, 49 (2): 569-574. 10.1016\/S0360-3016(00)01505-4.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Pt 2","key":"3901_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/bj3540233","volume":"354","author":"AW Griffioen","year":"2001","unstructured":"Griffioen AW, van der Schaft DW, Barendsz-Janson AF, Cox A, Struijker Boudier HA, Hillen HF, Mayo KH: Anginex, a designed peptide that inhibits angiogenesis. Biochem J. 2001, 354 (Pt 2): 233-242.","journal-title":"Biochem J"},{"issue":"1","key":"3901_CR37","first-page":"37","volume":"26","author":"K Kubota","year":"1985","unstructured":"Kubota K, Matsuzawa T, Ito M, Ito K, Fujiwara T, Abe Y, Yoshioka S, Fukuda H, Hatazawa J, Iwata R: Lung tumor imaging by positron emission tomography using C-11 L-methionine. J Nucl Med. 1985, 26 (1): 37-42.","journal-title":"J Nucl Med"},{"issue":"2","key":"3901_CR38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45 (2): 228-247. 10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"key":"3901_CR39","first-page":"86","volume-title":"Radiobiology for the Radiologist. Volume 7th","author":"EJ Hall","year":"2012","unstructured":"Hall EJ, Giaccia AJ: Oxygen effect and reoxygenation. Radiobiology for the Radiologist. Volume 7th. Edited by: Hall EJ, Giacca AJ. 2012, Philadephia: Lippincott, Williams & Wilkins, 86-103."},{"issue":"7","key":"3901_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2174\/187152012802650264","volume":"17","author":"K Kawakami","year":"2012","unstructured":"Kawakami K, Hattori M, Inoue T, Maruyama Y, Ohkanda J, Kato N, Tongu M, Yamada T, Akimoto M, Takenaga K: A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits growth in xenografts. Anti Cancer Agents Med Chem. 2012, 17 (7): 791-800.","journal-title":"Anti Cancer Agents Med Chem"},{"key":"3901_CR41","first-page":"153","volume-title":"Radiation Oncology Advances","author":"D Citrin","year":"2008","unstructured":"Citrin D, Camphausen K: Advancement of antiangiogenic and vascular disrupting agents combined with radiation. Radiation Oncology Advances. Edited by: Bentzen SM, Harari PM, Tome WA, Mehta MP. 2008, New York: Springer, LLC, 153-172."},{"issue":"10","key":"3901_CR42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1080\/09553000601002324","volume":"82","author":"JL Tatum","year":"2006","unstructured":"Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ: Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol. 2006, 82 (10): 699-757. 10.1080\/09553000601002324.","journal-title":"Int J Radiat Biol"},{"issue":"9","key":"3901_CR43","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/ijc.21694","volume":"118","author":"LP Smith","year":"2006","unstructured":"Smith LP, Thomas GR: Animal models for the study of squamous cell carcinoma of the upper aerodigestive tract: a historical perspective with review of their utility and limitations. Part A. Chemically-induced de novo cancer, syngeneic animal models of HNSCC, animal models of transplanted xenogeneic human tumors. Int J Cancer. 2006, 118 (9): 2111-2122. 10.1002\/ijc.21694.","journal-title":"Int J Cancer"},{"issue":"4","key":"3901_CR44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00330-006-0431-y","volume":"17","author":"AR Padhani","year":"2007","unstructured":"Padhani AR, Krohn KA, Lewis JS, Alber M: Imaging oxygenation of human tumours. Eur Radiol. 2007, 17 (4): 861-872. 10.1007\/s00330-006-0431-y.","journal-title":"Eur Radiol"},{"issue":"4","key":"3901_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.nucmedbio.2008.02.002","volume":"35","author":"KA Wood","year":"2008","unstructured":"Wood KA, Wong WL, Saunders MI: [(64)Cu]diacetyl-bis(N(4)-methyl-thiosemicarbazone)\u2014a radiotracer for tumor hypoxia. Nucl Med Biol. 2008, 35 (4): 393-400. 10.1016\/j.nucmedbio.2008.02.002.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"3901_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.nucmedbio.2010.08.009","volume":"38","author":"Y Yoshii","year":"2011","unstructured":"Yoshii Y, Furukawa T, Kiyono Y, Watanabe R, Mori T, Yoshii H, Asai T, Okazawa H, Welch MJ, Fujibayashi Y: Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma. Nucl Med Biol. 2011, 38 (2): 151-157. 10.1016\/j.nucmedbio.2010.08.009.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"3901_CR47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00259-009-1305-8","volume":"37","author":"AJ Weeks","year":"2010","unstructured":"Weeks AJ, Paul RL, Marsden PK, Blower PJ, Lloyd DR: Radiobiological effects of hypoxia-dependent uptake of 64Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells. Eur J Nucl Med Mol Imaging. 2010, 37 (2): 330-338. 10.1007\/s00259-009-1305-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3901_CR48","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1039\/b705989b","volume":"43","author":"AL Vavere","year":"2007","unstructured":"Vavere AL, Lewis JS: Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia. Dalton Trans. 2007, 43: 4893-4902.","journal-title":"Dalton Trans"},{"issue":"8","key":"3901_CR49","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.ejca.2004.01.020","volume":"40","author":"QG de Lussanet","year":"2004","unstructured":"de Lussanet QG, Beets-Tan RG, Backes WH, van der Schaft DW, van Engelshoven JM, Mayo KH, Griffioen AW, Beets-Tan RGH, van der Schaft DWJ, van Engelshoven JMA: Dynamic contrast-enhanced magnetic resonance imaging at 1.5 Tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice. Eur J Cancer. 2004, 40 (8): 1262-1268. 10.1016\/j.ejca.2004.01.020.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3901_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1088\/0031-9155\/53\/1\/015","volume":"53","author":"NF Black","year":"2008","unstructured":"Black NF, McJames S, Rust TC, Kadrmas DJ: Evaluation of rapid dual-tracer (62)Cu-PTSM + (62)Cu-ATSM PET in dogs with spontaneously occurring tumors. Phys Med Biol. 2008, 53 (1): 217-232. 10.1088\/0031-9155\/53\/1\/015.","journal-title":"Phys Med Biol"},{"issue":"11","key":"3901_CR51","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10350-008-9420-3","volume":"51","author":"DW Dietz","year":"2008","unstructured":"Dietz DW, Dehdashti F, Grigsby PW, Malyapa RS, Myerson RJ, Picus J, Ritter J, Lewis JS, Welch MJ, Siegel BA: Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study. Dis Colon Rectum. 2008, 51 (11): 1641-1648. 10.1007\/s10350-008-9420-3.","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"3901_CR52","first-page":"655","volume":"42","author":"JS Lewis","year":"2001","unstructured":"Lewis JS, Sharp TL, Laforest R, Fujibayashi Y, Welch MJ: Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med. 2001, 42 (4): 655-661.","journal-title":"J Nucl Med"},{"issue":"5","key":"3901_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12149-011-0471-5","volume":"25","author":"Y Minagawa","year":"2011","unstructured":"Minagawa Y, Shizukuishi K, Koike I, Horiuchi C, Watanuki K, Hata M, Omura M, Odagiri K, Tohnai I, Inoue T: Assessment of tumor hypoxia by 62Cu-ATSM PET\/CT as a predictor of response in head and neck cancer: a pilot study. Ann Nucl Med. 2011, 25 (5): 339-345. 10.1007\/s12149-011-0471-5.","journal-title":"Ann Nucl Med"},{"issue":"7","key":"3901_CR54","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","volume":"38","author":"M Ikawa","year":"2011","unstructured":"Ikawa M, Okazawa H, Kudo T, Kuriyama M, Fujibayashi Y, Yoneda M: Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET. Nucl Med Biol. 2011, 38 (7): 945-951. 10.1016\/j.nucmedbio.2011.02.016.","journal-title":"Nucl Med Biol"},{"issue":"6","key":"3901_CR55","doi-asserted-by":"publisher","first-page":"950","DOI":"10.2967\/jnumed.109.062216","volume":"50","author":"D Skovgaard","year":"2009","unstructured":"Skovgaard D, Kjaer M, Madsen J, Kjaer A: Noninvasive 64Cu-ATSM and PET\/CT assessment of hypoxia in rat skeletal muscles and tendons during muscle contractions. J Nucl Med. 2009, 50 (6): 950-958. 10.2967\/jnumed.109.062216.","journal-title":"J Nucl Med"},{"issue":"5","key":"3901_CR56","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0360-3016(02)04477-2","volume":"55","author":"F Dehdashti","year":"2003","unstructured":"Dehdashti F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ: Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.Int J Radiat Oncol Biol Phys. 2003, 55 (5): 1233-1238. 10.1016\/S0360-3016(02)04477-2.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"3901_CR57","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1158\/1078-0432.CCR-04-2048","volume":"11","author":"SS Nathan","year":"2005","unstructured":"Nathan SS, DiResta GR, Casas-Ganem JE, Hoang BH, Sowers R, Yang R, Huvos AG, Gorlick R, Healey JH: Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma. Clin Cancer Res. 2005, 11 (6): 2389-2397. 10.1158\/1078-0432.CCR-04-2048.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3901_CR58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.47102\/annals-acadmedsg.V38N12p1041","volume":"38","author":"SS Nathan","year":"2009","unstructured":"Nathan SS, Huvos AG, Casas-Ganem JE, Yang R, Linkov I, Sowers R, DiResta GR, Gorlick R, Healey JH: Tumour interstitial fluid pressure may regulate angiogenic factors in osteosarcoma. Ann Acad Med Singap. 2009, 38 (12): 1041-1047.","journal-title":"Ann Acad Med Singap"},{"key":"3901_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00003086-200104000-00034","volume":"385","author":"TA Zachos","year":"2001","unstructured":"Zachos TA, Aiken SW, DiResta GR, Healey JH: Interstitial fluid pressure and blood flow in canine osteosarcoma and other tumors. Clin Orthop Relat Res. 2001, 385: 230-236.","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"3901_CR60","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00259-003-1130-4","volume":"30","author":"F Dehdashti","year":"2003","unstructured":"Dehdashti F, Mintun MA, Lewis JS, Bradley J, Govindan R, Laforest R, Welch MJ, Siegel BA: In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM. Eur J Nucl Med Mol Imaging. 2003, 30 (6): 844-850. 10.1007\/s00259-003-1130-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"3901_CR61","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s00066-004-1229-y","volume":"180","author":"B Gagel","year":"2004","unstructured":"Gagel B, Reinartz P, Dimartino E, Zimny M, Pinkawa M, Maneschi P, Stanzel S, Hamacher K, Coenen HH, Westhofen M: pO(2) polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. Strahlenther Onkol. 2004, 180 (10): 616-622. 10.1007\/s00066-004-1229-y.","journal-title":"Strahlenther Onkol"},{"issue":"10","key":"3901_CR62","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00259-009-1154-5","volume":"36","author":"EJ Postema","year":"2009","unstructured":"Postema EJ, McEwan AJ, Riauka TA, Kumar P, Richmond DA, Abrams DN, Wiebe LI: Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA). Eur J Nucl Med Mol Imaging. 2009, 36 (10): 1565-1573. 10.1007\/s00259-009-1154-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"3901_CR63","doi-asserted-by":"publisher","first-page":"e1002336","DOI":"10.1371\/journal.pgen.1002336","volume":"7","author":"MT Cheeseman","year":"2011","unstructured":"Cheeseman MT, Tyrer HE, Williams D, Hough TA, Pathak P, Romero MR, Hilton H, Bali S, Parker A, Vizor L: HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants. PLoS Genet. 2011, 7 (10): e1002336-10.1371\/journal.pgen.1002336.","journal-title":"PLoS Genet"},{"key":"3901_CR64","first-page":"1400","volume-title":"Textbook of Veterinary Internal Medicine","author":"ME Peterson","year":"2000","unstructured":"Peterson ME: Hyperthyroidism. Textbook of Veterinary Internal Medicine. Edited by: Ettinger SJ, Feldman EC. 2000, Philadelphia: W.B. Saunders, 1400-1419."},{"issue":"2","key":"3901_CR65","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00268-009-0344-4","volume":"34","author":"A Itoh","year":"2010","unstructured":"Itoh A, Iwase K, Jimbo S, Yamamoto H, Yamamoto N, Kokubo M, Senda T, Nakai A, Nagagasaka A, Nagasaka T: Expression of vascular endothelial growth factor and presence of angiovascular cells in tissues from different thyroid disorders. World J Surg. 2010, 34 (2): 242-248. 10.1007\/s00268-009-0344-4.","journal-title":"World J Surg"},{"issue":"3","key":"3901_CR66","first-page":"858","volume":"299","author":"Z Zhong","year":"2001","unstructured":"Zhong Z, Li X, Yamashina S, von Frankenberg M, Enomoto N, Ikejima K, Kolinsky M, Raleigh JA, Thurman RG: Cyclosporin A causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine. J Pharmacol Exp Ther. 2001, 299 (3): 858-865.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"3901_CR67","first-page":"99","volume":"39","author":"GJ Cook","year":"1998","unstructured":"Cook GJ, Houston S, Barrington SF, Fogelman I: Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG. J Nucl Med. 1998, 39 (1): 99-103.","journal-title":"J Nucl Med"},{"issue":"11","key":"3901_CR68","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1158\/1078-0432.CCR-06-2441","volume":"13","author":"RP Dings","year":"2007","unstructured":"Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, Griffin RJ, Dings RPM, Loren M, Heun H: Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res. 2007, 13 (11): 3395-3402. 10.1158\/1078-0432.CCR-06-2441.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-218\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T11:51:25Z","timestamp":1688212285000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3901"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-218","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]},"article-number":"218"}}